{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:36:58Z","timestamp":1792795018159,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jconrel.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T19:11:45Z","timestamp":1657653105000},"page":"354-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis"],"prefix":"10.1016","volume":"349","author":[{"given":"Yang","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Mark","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.jconrel.2022.07.006_bb0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0010","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.006_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"issue":"7162","key":"10.1016\/j.jconrel.2022.07.006_bb0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.006_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/cr.2009.138","article-title":"Heterogeneity and plasticity of T helper cells","volume":"20","author":"Zhu","year":"2010","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090284","article-title":"IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model","volume":"9","author":"Chiricozzi","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.006_bb0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.jconrel.2022.07.006_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D33N39N8XM","article-title":"Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis","volume":"18","author":"Mudigonda","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.006_bb0050","first-page":"97","article-title":"Current developments in the immunology of psoriasis","volume":"93","author":"Gran","year":"2020","journal-title":"Yale J Biol Med"},{"issue":"7130","key":"10.1016\/j.jconrel.2022.07.006_bb0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.006_bb0060","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.3390\/ijms22062979","article-title":"Psoriasis: pathogenesis, comorbidities, and therapy updated","volume":"22","author":"Kanda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.07.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153299","article-title":"Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis","volume":"77","author":"Ru","year":"2020","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.006_bb0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/1523-1747.ep12582813","article-title":"Stratum corneum structure and function correlates with phenotype in psoriasis","volume":"107","author":"Ghadially","year":"1996","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.006_bb0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdermsci.2012.01.002","article-title":"Spectroscopic evidence of abnormal structure of psoriasis vulgaris stratum corneum","volume":"65","author":"Nakagawa","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.006_bb0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: a review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J. Dermatol."},{"issue":"19","key":"10.1016\/j.jconrel.2022.07.006_bb0085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.006_bb0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.006_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions","volume":"65","author":"G. American Academy of Dermatology Work","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"12","key":"10.1016\/j.jconrel.2022.07.006_bb0100","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jdv.13354","article-title":"European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC","volume":"29","author":"Nast","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.006_bb0105","first-page":"337","article-title":"Topical corticosteroids: choice and application","volume":"103","author":"Stacey","year":"2021","journal-title":"Am. Fam. Physician"},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2022.07.006_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1468-3083.2012.04523.x","article-title":"Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy","volume":"26","author":"Castela","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.006_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/ijo.IJO_1091_18","article-title":"Systemic toxicity of topical corticosteroids","volume":"67","author":"Jinagal","year":"2019","journal-title":"Indian J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.006_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ced.14473","article-title":"Topical corticosteroid vehicle composition and implications for clinical practice","volume":"46","author":"Oakley","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.006_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10856-021-06558-y","article-title":"Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis-a systematic review","volume":"32","author":"Shetty","year":"2021","journal-title":"J Mater Sci Mater Med"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.006_bb0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jps.22329","article-title":"Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles","volume":"100","author":"Zhang","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"3 Pt A","key":"10.1016\/j.jconrel.2022.07.006_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.006_bb0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nano.2012.11.010","article-title":"Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform","volume":"9","author":"Mandal","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0145","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212539","article-title":"Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review","volume":"7","author":"Ly","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2017.11.049","article-title":"Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications","volume":"270","author":"Rai","year":"2018","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.jconrel.2022.07.006_bb0155","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2174\/1381612826666200114090659","article-title":"Lipid vesicles and nanoparticles for non-invasive topical and transdermal drug delivery","volume":"26","author":"Shabbir","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.006_bb0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2010.503953","article-title":"Topical delivery for the treatment of psoriasis","volume":"7","author":"Mitra","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"issue":"12","key":"10.1016\/j.jconrel.2022.07.006_bb0165","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/nmat4422","article-title":"A sunblock based on bioadhesive nanoparticles","volume":"14","author":"Deng","year":"2015","journal-title":"Nat. Mater."},{"issue":"41","key":"10.1016\/j.jconrel.2022.07.006_bb0170","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1073\/pnas.1523141113","article-title":"Improved i.p. drug delivery with bioadhesive nanoparticles","volume":"113","author":"Deng","year":"2016","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0175","doi-asserted-by":"crossref","first-page":"15322","DOI":"10.1038\/ncomms15322","article-title":"Surface chemistry governs cellular tropism of nanoparticles in the brain","volume":"8","author":"Song","year":"2017","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.006_bb0180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020575118","article-title":"Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles","volume":"118","author":"Hu","year":"2021","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biomaterials.2017.08.029","article-title":"Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir","volume":"144","author":"Mohideen","year":"2017","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.006_bb0190","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4103\/0973-029X.102496","article-title":"Chemical and physical basics of routine formaldehyde fixation","volume":"16","author":"Thavarajah","year":"2012","journal-title":"J Oral Maxillofac Pathol"},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.006_bb0195","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bbagen.2007.06.014","article-title":"Physical characterization of the stratum corneum of an in vitro psoriatic skin model by ATR-FTIR and Raman spectroscopies","volume":"1770","author":"Bernard","year":"2007","journal-title":"Bba-Gen Subjects"},{"issue":"24","key":"10.1016\/j.jconrel.2022.07.006_bb0200","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1016\/j.biomaterials.2014.04.038","article-title":"The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles","volume":"35","author":"Deng","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.006_bb0205","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/antiox10091338","article-title":"Myeloperoxidase inhibition ameliorates plaque psoriasis in mice","volume":"10","author":"Neu","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.006_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0100-879X2004000100015","article-title":"Measurement of epidermal thickness in a patient with psoriasis by computer-supported image analysis","volume":"37","author":"Alper","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.006_bb0215","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4103\/0378-6323.72451","article-title":"Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors","volume":"76","author":"Katare","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jconrel.2022.07.006_bb0220","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2147\/IJN.S170832","article-title":"Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles","volume":"13","author":"Sun","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.006_bb0225","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.drudis.2018.05.033","article-title":"Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions","volume":"23","author":"Garg","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.006_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084237","article-title":"Drug delivery through the psoriatic epidermal barrier-a \u201cskin-on-A-Chip\u201d permeability study and ex vivo optical imaging","volume":"23","author":"Kocsis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.07.006_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2017.07.040","article-title":"Imiquimod-induced psoriasis-like inflammation in differentiated human keratinocytes: its evaluation using curcumin","volume":"813","author":"Varma","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.006_bb0240","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","article-title":"Advanced characterization of Imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.006_bb0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0536.1995.tb00470.x","article-title":"Surfactants and experimental irritant contact dermatitis","volume":"33","author":"Effendy","year":"1995","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.006_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/09546630701537678","article-title":"Washability and fabric-staining properties of a novel phospholipid-structured coal tar formulation","volume":"19","author":"Bhatia","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.006_bb0255","doi-asserted-by":"crossref","first-page":"adv00032","DOI":"10.2340\/00015555-3386","article-title":"Psoriasis and treatment: past, present and future aspects","volume":"100","author":"Reid","year":"2020","journal-title":"Acta Derm. Venereol."},{"issue":"7057","key":"10.1016\/j.jconrel.2022.07.006_bb0260","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.006_bb0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00403-010-1046-3","article-title":"A comparison of Ki-67 antigen presentation in acute generalized exanthematous pustulosis and pustular psoriasis","volume":"302","author":"Chang","year":"2010","journal-title":"Arch. Dermatol. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922004163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:25:55Z","timestamp":1759163155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922004163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":53,"alternative-id":["S0168365922004163"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}